Estrov Z - Search Results

1

Stimulation of the B-cell receptor activates the JAK2/STAT3 signaling pathway in chronic lymphocytic leukemia cells.

Rozovski U, Wu JY, Harris DM, Liu Z, Li P, Hazan-Halevy I, Ferrajoli A, Burger JA, O'Brien S, Jain N, Verstovsek S, Wierda WG, Keating MJ, Estrov Z. Rozovski U, et al. Among authors: estrov z. Blood. 2014 Jun 12;123(24):3797-802. doi: 10.1182/blood-2013-10-534073. Epub 2014 Apr 28. Blood. 2014. PMID: 24778152 Free PMC article.

2

Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors.

Estrov Z, Kurzrock R, Estey E, Wetzler M, Ferrajoli A, Harris D, Blake M, Gutterman JU, Talpaz M. Estrov Z, et al. Blood. 1992 Apr 15;79(8):1938-45. Blood. 1992. PMID: 1373331 Free article.

3

Differentiation in B-precursor acute lymphoblastic leukemia cell populations with CD34-positive subpopulations.

Re GG, Estrov Z, Antoun GR, Felix EA, Pinkel DP, Zipf TF. Re GG, et al. Among authors: estrov z. Blood. 1991 Aug 1;78(3):575-80. Blood. 1991. PMID: 1713508 Free article.

4

Suppression of chronic myelogenous leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: a novel application for inhibitors of IL-1 activity.

Estrov Z, Kurzrock R, Wetzler M, Kantarjian H, Blake M, Harris D, Gutterman JU, Talpaz M. Estrov Z, et al. Blood. 1991 Sep 15;78(6):1476-84. Blood. 1991. PMID: 1715791 Free article.

5

Erythropoietin treatment in patients with myelodysplastic syndrome and anemia.

Kurzrock R, Talpaz M, Estey E, O'Brien S, Estrov Z, Gutterman JU. Kurzrock R, et al. Among authors: estrov z. Leukemia. 1991 Nov;5(11):985-90. Leukemia. 1991. PMID: 1961041

6

Growth factors controlling interleukin-4 action on hematopoietic progenitors.

Ferrajoli A, Zipf TF, Talpaz M, Felix EA, Estrov Z. Ferrajoli A, et al. Among authors: estrov z. Ann Hematol. 1993 Dec;67(6):277-84. doi: 10.1007/BF01696347. Ann Hematol. 1993. PMID: 7506581

7

Interleukin 4 alters human bone marrow stroma and modulates its interaction with hematopoietic progenitors.

Ferrajoli A, Talpaz M, Ordonez NG, Stanley ER, Hirsch-Ginsberg C, Zipf TF, Wetzler M, Kurzrock R, Estrov Z. Ferrajoli A, et al. Among authors: estrov z. Stem Cells. 1994 Nov;12(6):638-49. doi: 10.1002/stem.5530120611. Stem Cells. 1994. PMID: 7533582

8

Elevated plasma thrombopoietic activity in patients with metastatic cancer-related thrombocytosis.

Estrov Z, Talpaz M, Mavligit G, Pazdur R, Harris D, Greenberg SM, Kurzrock R. Estrov Z, et al. Am J Med. 1995 Jun;98(6):551-8. doi: 10.1016/s0002-9343(99)80013-8. Am J Med. 1995. PMID: 7539977

9

Altered levels of interleukin-1 beta and interleukin-1 receptor antagonist in chronic myelogenous leukemia: clinical and prognostic correlates.

Wetzler M, Kurzrock R, Estrov Z, Kantarjian H, Gisslinger H, Underbrink MP, Talpaz M. Wetzler M, et al. Among authors: estrov z. Blood. 1994 Nov 1;84(9):3142-7. Blood. 1994. PMID: 7949186 Free article. Clinical Trial.

10

Inhibition of acute myelogenous leukemia progenitor proliferation by macrophage inflammatory protein 1-alpha.

Ferrajoli A, Talpaz M, Zipf TF, Hirsch-Ginsberg C, Estey E, Wolpe SD, Estrov Z. Ferrajoli A, et al. Among authors: estrov z. Leukemia. 1994 May;8(5):798-805. Leukemia. 1994. PMID: 8182937

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

506 results

Search Page

Filters